• No results found

Aspirin Therapy

Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients - a longitudinal observational study

Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients - a longitudinal observational study

... populations, aspirin therapy reduced the combined risk of myocardial infarction by 28% but had no effect on total mortality and stroke ...of aspirin and anti-platelet agents in diabetes come from ...

10

Low dose aspirin therapy and renal function in elderly patients

Low dose aspirin therapy and renal function in elderly patients

... Table 2 shows the stages of renal function based on the National Kidney Function/DOQI guideline: 86.67% exhib- ited their basal renal function in stages 1 and 2 based on CrCl. Figures 1–8 show the weekly assessment of ...

6

Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis

Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis

... to aspirin) for ARDS, and is the chief investigator of a multi-centre study investigating simvastatin as a therapy for ARDS (funded by the National Institute for Health and Research), is the chief ...

8

Long-term Aspirin Therapy for Hepatopulmonary Syndrome

Long-term Aspirin Therapy for Hepatopulmonary Syndrome

... associated intrapulmonary shunt in a patient with chronic liver disease: improvement after medical treatment. Am Rev Respir Dis[r] ...

6

Reye Syndrome Associated with Aspirin Therapy for Systemic Lupus Erythematosus

Reye Syndrome Associated with Aspirin Therapy for Systemic Lupus Erythematosus

... similar.1’9 Although encephalopathy in patients with Reye syndrome tends to be more severe than in most patients with aspirin hepatotoxicity, aspi- nin intoxication in young children may[r] ...

6

Treatment of Acute Kawasaki Disease: Aspirin’s Role in the Febrile Stage Revisited

Treatment of Acute Kawasaki Disease: Aspirin’s Role in the Febrile Stage Revisited

... without aspirin in acute stage of KD had no effect on the response rate of IVIG therapy, duration of fever, or incidence of CAAs when children were treated with high-dose (2 g/kg) IVIG as a single infusion, ...

7

Benefit and Safety of Dual Antiplatelet Therapy after Coronary Artery Bypass Grafting for Off-pump CABG: A Systematic Review and Meta-analysis

Benefit and Safety of Dual Antiplatelet Therapy after Coronary Artery Bypass Grafting for Off-pump CABG: A Systematic Review and Meta-analysis

... antiplatelet therapy. Dual antiplatelet therapy has a better benefit in reducing risk of vein graft occlusion and MI, also safer in reducing risk of postoperative mortality and not increasing risk of ...

15

Protocol for a systematic review of the diagnostic and prognostic utility of tests currently available for the detection of aspirin resistance in patients with established cardiovascular or cerebrovascular disease

Protocol for a systematic review of the diagnostic and prognostic utility of tests currently available for the detection of aspirin resistance in patients with established cardiovascular or cerebrovascular disease

... This will be a two-step process. Titles (and abstracts where available) will initially be screened by two reviewers, using pre-specified screening criteria. These are broadly based on whether the studies 1) are about ...

8

Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome

Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome

... is aspirin) therapy and sepsis or ...anti-platelet therapy have a lower admission rate to the ICU and shorter hospital stay ...platelet therapy have a decreased mortality [66, 67] and have a ...

9

Antithrombotic therapy after mitral valve repair: VKA or aspirin?

Antithrombotic therapy after mitral valve repair: VKA or aspirin?

... and aspirin strategy (group B) revealed no difference in the combined outcome of thromboembolic and bleeding complications as well as for both outcomes separately occurring within 3 months after ...the ...

9

Interventions for acute stroke management in Africa: a systematic review of the evidence

Interventions for acute stroke management in Africa: a systematic review of the evidence

... thrombolytic therapy through tissue plasminogen activator (t-PA) for acute ischemic stroke within ...[17–20], aspirin therapy for acute ischaemic stroke within 48 h of a stroke [21] and decompressive ...

12

Bleeding due to post-bypass haemostatic dysfunction: An investigation of mechanisms, prevention and therapy

Bleeding due to post-bypass haemostatic dysfunction: An investigation of mechanisms, prevention and therapy

... pre-operative aspirin therapy up to the time of cardiac surgery is defined in a prospective, randomised, placebo controlled, double blind clinical trial in 100 patients scheduled to undergo elective ...

284

Use of warfarin in long-term care: a systematic review

Use of warfarin in long-term care: a systematic review

... primary therapy for stroke prophylaxis in AF, but suggest that a systematic assessment of stroke and bleeding risk be per- formed prior to initiation of therapy ...

33

Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary intervention

Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary intervention

... clopidogrel therapy based on platelet activity but is limited by its small sample ...tailored therapy using platelet functional testing versus standard therapy and should help clarify whether there ...

12

Comparative effect of clopidogrel and aspirin versus aspirin alone on laboratory parameters: a retrospective, observational, cohort study

Comparative effect of clopidogrel and aspirin versus aspirin alone on laboratory parameters: a retrospective, observational, cohort study

... plus aspirin and aspirin alone on laboratory tests focusing on a short-term administration period up to two months, but was not a long-term study that ana- lyzed longitudinal data, including repeated ...

7

The antithrombotic therapy of atrial fibrillation in patients with coronary heart disease

The antithrombotic therapy of atrial fibrillation in patients with coronary heart disease

... triple therapy with Aspirin, Clopidogrel or Ticagrelor and oral anticoagulant will ever be ...antithrombotic therapy, taking into account the high risk of bleeding, the risk of stroke and stent ...

5

The effect of esomeprazole vs famotidine on aspirin/clopidogrel dual therapy after percutaneous coronary intervention

The effect of esomeprazole vs famotidine on aspirin/clopidogrel dual therapy after percutaneous coronary intervention

... antiplatelet therapy, the loading was 300 mg of aspirin (Bayer HealthCare AG, Leverku- sen, Germany) and 600 mg of clopidogrel (Sanofi Aventis, Bridgewater, ...of aspirin and 75 mg daily of clopi- ...

6

Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial

Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial

... of aspirin and proton pump inhibitor (PPI) usage were associated with increased risk of haemorrhage regardless of treatment group (survival fi ...of aspirin usage and concomitant usage of PPI could predict ...

8

Practice Parameter: Recurrent stroke with patent foramen ovale and atrial septal aneurysm: [RETIRED]Report of the Quality Standards Subcommittee of the American Academy of Neurology*

Practice Parameter: Recurrent stroke with patent foramen ovale and atrial septal aneurysm: [RETIRED]Report of the Quality Standards Subcommittee of the American Academy of Neurology*

... PICSS is classified as a class II study for addressing this question. It was a prospective cohort study that was built into the larger WARSS randomized clinical trial, but patients were randomized to therapy with- ...

10

The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population- an updated meta-analysis

The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population- an updated meta-analysis

... prevention for chronic phase of ischemic stroke was based on one placebo-controlled RCT, which was not an effect size. This same limitation also existed in the results of acute phase. Caution should be used when applying ...

10

Show all 10000 documents...

Related subjects